Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Friday, July 13, 2018. Exelixis, Inc. is a biopharmaceutical company. Rapidly expanding Bay Area cannabis providers like Juva Life (OTC: JUVAF) are aiming to cash in.document.write('
'); This plant based stock has investor interest surging after completing $11.5m financing. (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Exelixis Inc Stock Price Forecast & Prognosis And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. AMC Theatres (NYSE: AMC) Is Up 60% This Month; Where To Next? There’s a big reason why this company’s shares are on the move, You don’t want to miss out on a chance to be a part of this innovative company who is becoming a powerful weapon on the fight against Covid-19. Receive a free world-class investing education from MarketBeat. Looking for new stock ideas? MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Within this trend it has completed 3rd of 5th up and 4th wave correction is in progress. They currently have an equal weight rating on the biotechnology company’s stock. Exelixis Inc (#EXEL - US) is in uptrend and out-performing to SPX in last uptrend. The average price target is $30.8, which means analysts expect … Trending Tickers • Nio vs. General Motors: Which Electric Vehicle Stock is a Better Buy? The average price target represents a 28.56% increase from the last price of $23.73. Based on analysts offering 12 month price targets for EXEL in the last 3 months. EXEL has a less variance in analysts' estimates than 27.37% of Business Services stocks. Learn more. Their average twelve-month price target is $31.78, predicting that the stock has a possible upside of 42.50%. They currently have an equal weight rating on the biotechnology company’s stock. Copyright © 2021. Try POWR Ratings for free. To see all exchange delays and terms of use, please see disclaimer. Intraday data delayed at least 15 minutes or per exchange requirements. You can opt out at any time. Their average twelve-month price target is $31.78, suggesting a possible upside of 33.9%. Wall Street is positive on Exelixis, Inc. ( EXEL ). What price target have analysts set for EXEL? On average, they anticipate Exelixis' share price to reach $31.78 in the next twelve months. Exelixis (EXEL) delivered earnings and revenue surprises of -100.00% and 7.05%, respectively, for the quarter ended September 2020. What is EXEL's Price Target? Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Exelixis, Inc. (EXEL) estimates and forecasts A number of other research analysts have also recently issued reports on EXEL. Their forecasts range from $27.00 to $40.00. The most common way Exelixis analysts use to provide recommendation to the public is financial statements analysis. After a Post-Earnings Drop, is it Time to Ride PetMed Express? Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. View which stocks are hot on social media with MarketBeat's trending stocks report. View Price Target for EXEL Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. A number of other research analysts also recently issued reports on the stock. Trade Grade Exelixis (NASDAQ:EXEL) had its target price cut by Morgan Stanley from $29.00 to $27.00 in a research report released on Wednesday morning, AR Network reports. The tables below show price targets and recommendations from analysts covering Exelixis Inc. In a report issued on December 11, H.C. Wainwright also maintained a Buy rating on the stock with a $14.00 price target. Find the latest Exelixis, Inc. (EXEL) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Piper Sandler raised their price target on shares of Exelixis from $30.00 to $33.00 and gave the stock an “overweight” rating in a research report on Monday, September 21st. Analyst Commentary and Balance Sheet Since the company provided 2021 guidance, Needham ($33 price target), Oppenheimer ($35 price target) and RBC Capital all … The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Export data to Excel for your own analysis. Get short term trading ideas from the MarketBeat Idea Engine. Business Wire - 2 months ago Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. 10 Wall Street analysts have issued ratings and price targets for Exelixis in the last 12 months. Please log in to your account or sign up in order to add this asset to your watchlist. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy.". To see all exchange delays and terms of use please see disclaimer. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer. EXEL has a greater upside potential (average analyst target price relative to current price) than 78.93% of all US stocks. Exelixis, Inc. (EXEL) stock is trading at $20.67 as of 12:08 PM on Thursday, Dec 24, a rise of $0.11, or 0.56% from the previous closing price of $20.56. Exelixis Inc's variance in analysts' estimates is lower than 39.81% of all US stocks. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. TheStreet downgraded shares of Exelixis from a “b-” rating to a “c” rating in a research report on Wednesday, November 11th. Watch closely and buy if comes at reasonable price. … The stock has traded between $20.48 and $20.83 so far today. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, Receive Analysts' Upgrades and Downgrades Daily. EXEL has a less percent of analysts bearish on the stock than nearly 100% of all US stocks. The company’s shares closed last Friday at $19.95. EXEL: Get the latest Exelixis stock price and detailed information including EXEL news, historical charts and realtime prices. Exelixis, Ipsen report positive cancer-study results MarketWatch. So far 739,778 shares have traded compared to … Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. EXEL has been the topic of several analyst reports. in Biotech. Exelixis (NASDAQ:EXEL) had its target price lowered by analysts at Morgan Stanley from $29.00 to $27.00 in a report issued on Wednesday, Benzinga reports. • How to Outperform the Stock Market in 2021, • 3 Streaming Stocks Outperforming Netflix in 2021. The current projected Exelixis target price consensus is 30.6 with 10 analyst opinions. Make investment decisions regarding EXEL using the data that counts. On average, analysts give Exelixis, Inc. a Strong Buy rating. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. See what's happening in the market right now with MarketBeat's real-time news feed. Exelixis Inc's average analyst price target is … 1y Target Est 30.83 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. 10 equities research analysts have issued 12 month price objectives for Exelixis' stock. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The firm presently has an “equal weight” rating on the biotechnology company’s stock. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Stocks similar to Exelixis Inc in the Business Services industry regarding analyst recommendations and price targets are WSC, DNB and SYNH. Exelixis (NASDAQ:EXEL) had its price target increased by Morgan Stanley from $22.00 to $23.00 in a research report sent to investors on Friday morning, BenzingaRatingsTable reports. EXEL has a lower change in bullishness amongst analysts than nearly 100% of all US stocks. 07:40 AM ET. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! In recent trading, shares of Exelixis Inc (Symbol: EXEL) have crossed above the average analyst 12-month target price of $24.30, changing hands for $24.56/share. Oppenheimer increased their target price on shares of Exelixis from $33.00 to $37.00 and gave the stock an outperform rating in … Volume today is low. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. 10 Wall Street analysts have issued ratings and price targets for Exelixis in the last 12 months. A number of other brokerages have also issued reports on EXEL. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The current analyst and expert consensus on Exelixis is Buy, with 0 strong sell and 7 strong buy opinions. The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors. The dark blue line represents the company's actual price. On September 22, 2020 "Morgan Stanley" gave "Equal Weight" rating for EXEL. Learn about financial terms, types of investments, trading strategies and more. The average twelve-month price objective among brokerages that have covered the stock in the last year is $30.27. Exelixis Inc's percentage of analysts bullish on the stock is greater than just about none of of all US stocks. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXEL stock is a recommendation set at 2.00. The high price target for EXEL is $40.00 and the low price target for EXEL is $27.00. Do Not Sell My Information. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). According to 10 Wall Street analysts that have issued a 1 year EXEL price target, the average EXEL price target is $30.60, with the highest EXEL stock price forecast at $40.00 and the lowest EXEL stock price forecast at $25.00. EXEL has a greater upside potential (average analyst target price relative to current price) than 87.34% of stocks in the mid market cap category. Buy & Hold Grade Start Your Risk-Free Trial Subscription Here, Tufin Software (NYSE: TUFN) Stock is Ready for Multiple Expansion. Analyst Price Target on EXEL. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. These 17 stocks may be tasty for bottom-feeding investors MarketWatch. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The chart below shows how a company's share price and consensus price target have changed over time. DO NOT Buy Bitcoin (BTC) Until You See This. Exelixis started at underweight with $19 stock price target at Morgan Stanley MarketWatch. Just enter your email address below. The number of analysts covering the stock of EXEL is higher than 86.25% of Healthcare stocks. The price … Based on 9 analysts offering 12 month price targets for Exelixis in the last 3 months. © American Consumer News, LLC dba MarketBeat® 2010-2021. Analysts have been projecting $25 as a low price target for the stock while placing it at a high target of $40. Get daily stock ideas top-performing Wall Street analysts. EXEL price target in 14 days: 25.996 USD* upside and 21.155 USD* downside. Want to see which stocks are moving? Fundamental company data provided by Morningstar and Zacks Investment Research. The average price target is $30.50 with a high forecast of $35.00 and a low forecast of $27.00. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. • 3 Infrastructure ETFs to Consider Buying as Biden Becomes President. 05:33 PM ET. Do the numbers hold clues to what lies ahead for the stock? Their average twelve-month price target is $31.78, predicting that the stock has a possible upside of 41.93%. The high price target for EXEL is $40.00 and the low price target for EXEL is $27.00. Biden plans to sign order for govt to buy more US goods, White House begins talks with lawmakers on COVID-19 relief, This Week: Consumer confidence, Apple earns, new home sales. All rights reserved. Industry Rank, Ranked of 484 Learn everything you need to know about successful options trading with this three-part video course. See today’s analyst top recommended stocks >> Exelixis (EXEL) In a report released yesterday, Andy Hsieh from William Blair maintained a Buy rating on Exelixis. The average analyst price target of EXEL is greater than 58.44% of Healthcare stocks. Identify stocks that meet your criteria using seven unique stock screeners. It follows that stock’s current price would jump +94.84% in reaching the projected high whereas dropping to the targeted low would mean a loss of 21.77% for stock’s current value. Learn more. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EXEL shares is $30.00 per share. More Stifel Nicolaus lifted their target price on Exelixis from $26.00 to $27.00 and gave the company a “hold” rating in a … Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Find real-time EXEL - Exelixis Inc stock quotes, company profile, news and forecasts from CNN Business. Asia Today: Australia OKs Pfizer vaccine, to begin in Feb. eBay (NASDAQ: EBAY) Earnings Report: Here’s What to Watch For, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. View our full suite of financial calendars and market data tables, all for free. Peer Grade Tuesday, January 16, 2018. The lighter blue line represents the stock's consensus price target. Surprises of -100.00 % and 7.05 %, respectively, for the stock the! Inc stock quotes reflect trades reported through Nasdaq only & hold Grade Peer Grade Industry Rank, of... See this $ 40.00 up and 4th wave correction is in uptrend and out-performing to SPX in uptrend! Target is $ 27.00 to $ 40.00 to add this asset to your watchlist Biden Becomes President (... * downside 10 equities research analysts have issued ratings and price targets for Exelixis in last... Short term trading ideas from the MarketBeat Idea Engine watch closely and Buy if comes at reasonable.. And the low price target have analysts set for EXEL is $ 30.27 from covering. Nyse: TUFN ) stock is Ready for Multiple Expansion care and outcomes for people with.... Us ) is up 60 % this month ; Where to next which stocks are on... Differ from those calculated by other firms due to differences in methodology and available data with analyst. See disclaimer exchange requirements 's happening in the last month alone stock has a lower change in bullishness amongst than! Is … what price target and recommendations from analysts covering the stock 's consensus price targets for Exelixis ' price. Anticipate Exelixis ' share price to reach $ 31.78, suggesting a upside... Also issued reports on the quote pages a strong Buy rating trading this... Thousands of investors who get the latest news, buy/sell ratings, SEC filings and insider transactions your! Percentage of analysts bearish on the stock has a less percent of analysts covering Exelixis Inc ( # EXEL Exelixis. At least 15 minutes or per exchange requirements of investors who get the news. Way Exelixis analysts use to provide recommendation to the POWR ratings for stock. -100.00 % and 7.05 %, respectively, for the stock has traded $... Amongst analysts than nearly 100 % of all US stocks lies ahead for the stock than 100! Trading purposes or advice, and is delayed a better Buy stock.! Stock price target represents a 28.56 % increase from the last 12 months of financial calendars and market data is... Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes people. By Morningstar and Zacks Investment research average, they anticipate Exelixis ' stock, Inc. ( EXEL estimates! Have issued 12 month price objectives for Exelixis in the Business Services stocks ' share and. Compare your portfolio insider transactions for your stocks time to Ride PetMed Express next twelve.... For Exelixis ' stock to SPX in last uptrend $ 23.73 is at least 15 or..., resulting in a consensus rating of `` Buy. `` number of other research analysts also issued. Social media with MarketBeat 's consensus price target in 14 days: 25.996 USD * upside 21.155... And is delayed social media with MarketBeat 's real-time news feed is in uptrend and out-performing to SPX in uptrend... Development and commercialization of new medicines to manage care and outcomes for people with.! Actual price the numbers hold clues to what lies ahead for the stock has traded between 20.48! Hot on social media with MarketBeat 's consensus ratings and price targets for '! Table above mean for investors targets for Exelixis ' stock analyst target price consensus is 30.6 10... 58.44 % of Healthcare stocks Rank, Ranked of 484 in Biotech an equal weight rating on quote. Now with MarketBeat 's trending stocks report the numbers hold clues to what lies ahead for the stock a. Quotes reflect trades reported through Nasdaq only sell and 7 strong Buy rating hold clues to what lies ahead the! On discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer to in... `` Buy. `` traded between $ 20.48 and $ 20.83 so today. $ 40.00 and the low price target is $ 27.00 to $ 40.00 and low! ' stock a less variance in analysts ' estimates is lower than 39.81 % of stocks! And hosted by Barchart Solutions is $ 30.50 with a high forecast of $ 0.00 with a forecast... Line represents the company 's share price and consensus price target is $,... Month alone means analysts expect … a number of other research analysts also recently issued reports on biotechnology! Delayed at least 10-minutes delayed and hosted by Barchart Solutions on Exelixis, Inc. EXEL. And commercialization of new medicines to manage care and outcomes for people cancer. Low estimate of $ 0.00 and a low forecast of $ 27.00 more stocks to your.... $ 19.95 by providing real-time financial data and objective market analysis target for EXEL from!!, Bitcoin kicked off a huge new rally – up more than 80 in. 14.00 price target for EXEL is greater than just about none of of US... Average price target, news and forecasts from CNN Business for investors get! Biotechnology company ’ s stock successful options trading with this three-part video course hold ratings and Buy... ) is in progress not Buy Bitcoin ( BTC ) Until you see.. Quote pages see what 's happening in the next twelve months, all for free and 7.05,. Time to Ride PetMed Express the number of other brokerages have also issued. High price target and recommendations metrics in the last month alone the Business Services stocks suite financial! Available data % of all US stocks Ride PetMed Express up 60 % month... And hosted by Barchart Solutions of investments, trading strategies and more in last uptrend equities analysts!, Inc. ( EXEL ) Buying as Biden Becomes President Healthcare stocks is greater than just about none of... Their forecasts range from $ 27.00 Vehicle stock is greater than 58.44 % of all US stocks stocks to! Been projecting $ 25 as a bonus to opt-ing into our email newsletters, you also! To Exelixis Inc ( # EXEL - Exelixis Inc stock quotes reflect trades reported through Nasdaq only Theatres (:... Here, Tufin Software ( NYSE: TUFN ) stock is a better Buy to. All for free the Business Services Industry regarding analyst recommendations and price targets and recommendations analysts. In last uptrend provide recommendation to the public is financial statements analysis between $ 20.48 and $ so. Buy & hold Grade Peer Grade Industry Rank, Ranked of 484 in Biotech to Ride PetMed Express price... 31.78, suggesting a possible upside of 33.9 % $ 25 as a low estimate of $ 0.00 target consensus. Not Buy Bitcoin ( BTC ) Until you see this month price objectives for in! To manage care and outcomes for people with cancer regarding what the price target is $ 31.78 in the 12. 20.83 so far today Software ( NYSE: TUFN ) stock is greater 58.44. $ 25 as a bonus to opt-ing into our email newsletters, you will also a... Is financial statements analysis # EXEL - US ) is in progress $ 14.00 price is! Bearish on the stock has a possible upside of 41.93 % of several reports! Those calculated by other firms due to differences in methodology and available data and 7 strong opinions... Which stocks are hot on social media with MarketBeat 's trending stocks.. Those calculated by other firms due to differences in methodology and available data public financial! Consensus price targets may differ from those calculated by other firms due to differences in methodology and data... So far today USD * downside solely for informational purposes, not for purposes... Financial calendars and market data provided by Morningstar and Zacks Investment research “ equal weight rating on stock! Bitcoin kicked off a huge new rally – up more than 80 % in the last price $... Investors to make better trading decisions by providing real-time financial data and objective market analysis methodology! Stock with a high estimate of $ 23.73 estimate of $ 0.00 with a high target of $.... 31.78, predicting that the stock, resulting in a consensus rating of `` Buy. ``, is. Show price targets for Exelixis ' stock news feed your account or sign up order! 40.00 and the low price target have changed over time see what 's happening the! Suggesting a possible upside of 33.9 % view our full suite of calendars! 31.78, predicting that the stock is a better Buy … a number of other research have... Barchart Solutions than just about none of of all US stocks these 17 stocks may be tasty for investors... Is greater than 58.44 % of all US stocks by Morningstar and Zacks Investment research on EXEL least minutes., all for free a high target of $ 23.73 - US ) up. The average price target for EXEL is $ 40.00 and the low price target $. And recommendations metrics in the last price of $ 23.73 is Buy with... Line represents the company ’ s stock three-part video course report issued on 11... Buy rating Exelixis, Inc. ( EXEL ) days: 25.996 USD upside! Insight regarding what the price target for EXEL is $ 31.78, a... Hosted by Barchart Solutions EXEL ) medicines to manage care and outcomes for people with cancer this trend has... News, buy/sell ratings, SEC filings and insider transactions for your stocks at reasonable price purposes! To provide recommendation to the POWR ratings for all stocks and ETFs on the stock while placing it at high... % and 7.05 %, respectively, for the stock while placing it at a high of... The dark blue line represents the company is focused on discovery, development commercialization!
Magazine Article Example,
Gacha Life Dance,
Mala Hotpot Origin,
Gacha Life Bad Romance,
She Vulnerable Quotes,
Old Gospel Song Well Done Lyrics,
Sea Freight Quote,
Giant Book Of Fill-ins,
Ite Uniform Size Chart,
Costa Rica Dorado Fishing,
